T-cell counts and what they mean. Clearinghouse, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5023. NLM AIDSLINE Important note: Information in this article was accurate in 1995. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


T-cell counts and what they mean. Clearinghouse, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5023.

AIDS Clin Care. 1995 Apr;7(4):31-2. Unique Identifier : AIDSLINE AIDS/95700182
Langlois W; Sax P; Harvard Community Services Center, Cleveland, OH.


Abstract: The blood contains red, oxygen-carrying cells and white, immune-system cells. The T-cell count measures white blood cells, and is determined by multiplying together the following three numbers: 1) the total number of white blood cells; 2) the percentage of white blood cells that are lymphocytes; and 3) the percentage of lymphocytes that are T-helper cells. (Lymphocytes are a specialized kind of white blood cell that tell other immune system cells how to fight infections.) The T-cell count is important because HIV directly infects and damages T-cells, causing the number of T-cells in an HIV-infected person to decrease over time. When HIV disease progresses and the T-cell count drops, the immune system is less able to fight off invading germs. Therefore, the likelihood of contracting an infection, especially an opportunistic infection, increases. Decreasing T-cell counts may encourage the patient to take prophylactic (preventative) medicines in order to counteract the increasing risk of opportunistic infections. T-cell counts may also influence the decision to begin anti-HIV therapy, such as AZT. Although T-cell counts can offer a certain amount of information, they only serve as one measure of the patient's health.
Keywords: Acquired Immunodeficiency Syndrome/BLOOD/DRUG THERAPY/IMMUNOLOGY Human HIV Infections/BLOOD/DRUG THERAPY/IMMUNOLOGY *Lymphocyte Count *T-Lymphocyte Subsets NEWSLETTER ARTICLE

KWDacquiredimmunodeficiencysyndrome/blood/drugtherapy/immunologyhumanhivinfections/blood/drugtherapy/immunologyKWDlymphocytecountKWDt-lymphocytesubsetsnewsletterarticle
951130
M95B0924


Copyright © 1995 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1995. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1995. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .